Trial intelligence / Profile preview

REACH UP: Rolofylline in Acute Heart Failure

NCT00443690Phase 3Completed

Sponsor
Merck & Co.
Start
Aug 2007
Primary completion
Jan 2009
Modality
Orthosteric Ligands
01

Overview

A Phase 3 trial of rolofylline in heart failure (HF), sponsored by Merck & Co.. Started Aug 2007; status: completed.

02

Drugs

rolofylline
03

Conditions

heart failure (HF)

Beyond the preview

Go deeper on NCT00443690.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00443690.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call